Searched by
Animal species - Human
| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | |||||
|
TC-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | |||||
|
TS-M040-4 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | 4°C | |||||
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | |||||
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | 4°C | |||||
|
TS-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
|
||||
|
virus | PE | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | |||||
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
TS-M048-4 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| YMLDLQPETT | 11-20 | 4°C | |||||
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | ||||||
|
TC-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | |||||
|
TC-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | |||||
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | |||||
|
TS-M043-4 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| ALYDVVSKL | 2594-2602 | 4°C | |||||
|
TS-M057-4 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| VLEETSVML | 316-324 | 4°C | |||||
|
TS-M053-4 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| FLLSLGIHL | 575-583 | 4°C | |||||
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | |||||
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TS-M124-4 |
HLA-A*03:01 EBV BRLF1 Tetramer-RVRAYTYSK-BV421 |
|
||||
|
virus | BV421 | A*03:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| RVRAYTYSK | 4°C | ||||||
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | ||||||
|
TC-0116-2 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | ||||||
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | |||||
|
TC-0116-4 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | ||||||
|
TC-0118-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | ||||||
|
TC-0121-4 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | ||||||
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | 4°C | |||||
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥219,500 | 1-9 | |
| FLWGPRALV | 271-279 | 4°C | |||||
|
TC-0121-2 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALPHIIDEV | 4°C | ||||||
|
TC-0146-2 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | |||||
|
TC-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
|
||||
|
Others | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | 4°C | |||||
|
TC-0173-2 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | 4°C | |||||
|
TC-0102-2 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-APC |
|
||||
|
Others | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HLVEALYLV | 4°C | ||||||
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | |||||
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | |||||
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | ||||||
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | 4°C | |||||
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
TC-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CVNGVCWTV | 4°C | ||||||
|
TC-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLLTRILTI | 4°C | ||||||
|
TC-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | |||||
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | |||||
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | |||||
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | ||||||
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | |||||
|
TS-M122-4 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-BV421 |
|
||||
|
virus | BV421 | A*02:01 | 50 tests | ¥219,500 |
0 (Contact us) |
|
| ALWALPHAA | 593-601 | 4°C | |||||
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | ||||||
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | |||||
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | |||||
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | |||||
|
TC-0165-2 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILGFVFTLTV | 4°C | ||||||
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | ||||||
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | |||||
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | ||||||
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TC-0131-2 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-APC |
|
||||
|
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | |||||
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | |||||
|
TC-8001-1 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | |||||
|
TC-8031-2 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | |||||
|
TC-8010-2 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | |||||
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | 4°C | |||||
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | |||||
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | 4°C | |||||
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC |
|
||||
|
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | |||||
|
TC-8004-1 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | |||||
|
TC-8023-2 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | |||||
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | 4°C | |||||
|
TC-8032-1 |
HLA-A*03:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TC-8016-1 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-PE |
|
||||
|
Others | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | 4°C | |||||
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | |||||
|
TS-M274-1 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| CVRVSGQGL | 4°C | ||||||
|
TC-8016-2 |
HLA-A*11:01 EGFR852-860 L858R Tetramer-KITDFGRAK-APC |
|
||||
|
Others | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KITDFGRAK | 852-860 | 4°C | |||||
|
TC-8025-1 |
HLA-A*11:01 HPV16 E789-97 Tetramer-IVCPICSQK-PE |
|
||||
|
virus | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| IVCPICSQK | 89-97 | 4°C | |||||
|
TS-M202-2 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | ||||||
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE |
|
||||
|
virus | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | |||||
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLYEEPLLK | 4°C | ||||||
|
TS-M243-1 |
HLA-A*02:01 UGCGL2 Neoepitope Tetramer-GLLDEDFYA-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLDEDFYA | 4°C | ||||||
|
TC-8021-2 |
HLA-A*11:01 KRAS7-16 G12A Tetramer-VVVGAAGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAAGVGK | 7-16 | 4°C | |||||
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | 4°C | |||||
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE |
|
||||
|
cancer | PE | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | 4°C | ||||||
|
TC-8015-1 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | |||||
|
TS-M251-2 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | ||||||
|
TC-8002-2 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | 4°C | |||||
|
TS-M271-1 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | ||||||
|
TC-8023-1 |
HLA-A*11:01 KRAS7-16 G12S Tetramer- VVVGASGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGASGVGK | 7-16 | 4°C | |||||
|
TC-8022-1 |
HLA-A*11:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | 4°C | |||||
|
TC-8012-1 |
HLA-A*11:01 KRAS7-16 G12R Tetramer-VVVGARGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGARGVGK | 7-16 | 4°C | |||||
|
TS-M271-2 |
HLA-B*07:02 GNB5 Neoepitope Tetramer-RVSTLRVSL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RVSTLRVSL | 4°C | ||||||
|
TS-M272-1 |
HLA-B*07:02 MLL3 Neoepitope Tetramer-KPSDTPRPVM-PE |
|
||||
|
cancer | PE | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KPSDTPRPVM | 4°C | ||||||
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | 4°C | |||||
|
TC-8004-2 |
HLA-A*11:01 KRAS8-16 G12V Tetramer-VVGAVGVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAVGVGK | 8-16 | 4°C | |||||
|
TS-M251-1 |
HLA-A*03:01 SIRT2 Neoepitope Tetramer-KIFSEVTLK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KIFSEVTLK | 4°C | ||||||
|
TC-8015-2 |
HLA-A*11:01 KRAS7-16 G13D Tetramer-VVVGAGDVGK-APC |
|
||||
|
cancer | APC | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVVGAGDVGK | 7-16 | 4°C | |||||
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | |||||
|
TS-M252-2 |
HLA-A*03:01 PRPF6 Neoepitope Tetramer-KILDAVVAQK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KILDAVVAQK | 4°C | ||||||
|
TS-M267-1 |
HLA-A*24:02 LOK Tetramer-SYQKVIELF-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYQKVIELF | 289-297 | 4°C | |||||
|
TS-M241-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | ||||||
|
TC-8005-1 |
HLA-A*11:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | 4°C | |||||
|
TS-M258-1 |
HLA-A*11:01 KRAS Neoepitope Tetramer-VVGAAGVGK-PE |
|
||||
|
cancer | PE | A*11:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VVGAAGVGK | 4°C | ||||||